rs610604
Orientation | minus |
Stabilized | minus |
Make rs610604(A;A) |
Make rs610604(A;C) |
Make rs610604(C;C) |
Reference | GRCh38 38.1/141 |
Chromosome | 6 |
Position | 137878280 |
Gene | TNFAIP3 |
is a | snp |
is | mentioned by |
dbSNP | rs610604 |
dbSNP (classic) | rs610604 |
ClinGen | rs610604 |
ebi | rs610604 |
HLI | rs610604 |
Exac | rs610604 |
Gnomad | rs610604 |
Varsome | rs610604 |
LitVar | rs610604 |
Map | rs610604 |
PheGenI | rs610604 |
Biobank | rs610604 |
1000 genomes | rs610604 |
hgdp | rs610604 |
ensembl | rs610604 |
geneview | rs610604 |
scholar | rs610604 |
rs610604 | |
pharmgkb | rs610604 |
gwascentral | rs610604 |
openSNP | rs610604 |
23andMe | rs610604 |
SNPshot | rs610604 |
SNPdbe | rs610604 |
MSV3d | rs610604 |
GWAS Ctlg | rs610604 |
GMAF | 0.3627 |
Max Magnitude | 0 |
? | (A;A) (A;C) (C;C) | 28 |
---|---|---|
|
23andMe blog psoriasis Europeans
- rs610604(G) 1.19x risk
GWAS snp | |
---|---|
PMID | [PMID 19169254] |
Trait | Psoriasis |
Title | Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways |
Risk Allele | G |
P-val | 9E-12 |
Odds Ratio | 1.19 None |
GWAS snp | |
---|---|
PMID | [PMID 20953190] |
Trait | |
Title | A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1 |
Risk Allele | |
P-val | 7E-7 |
Odds Ratio | 1.2200 [1.13-1.32] |
[PMID 21623003] Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis
[PMID 22113471] TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis.
[PMID 17259397] Tag polymorphisms at the A20 (TNFAIP3) locus are associated with lower gene expression and increased risk of coronary artery disease in type 2 diabetes.
[PMID 19262574] Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis.
[PMID 21253569] Genome-wide association study SNPs in the human genome diversity project populations: does selection affect unlinked SNPs with shared trait associations?
[PMID 23161053] TNFAIP3 gene polymorphisms confer risk for Behcet's disease in a Chinese Han population
[PMID 23521149] Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab.
[PMID 25496073] The TNFAIP3 polymorphism rs610604 both associates with the risk of psoriasis vulgaris and affects the clinical severity
[PMID 26005883] Lack of association of TNFAIP3 and JAK1 with Behçet's disease in the European population